68Ga-AAZTA-093 PET/CT: First-in-human Study

NCT06437496 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Prostate

Interventions

DRUG: 68Ga-AAZTA-093
DRUG: 68Ga-PSMA-11//68Ga-PSMA-617

Sponsor

First Affiliated Hospital of Fujian Medical University